The agenda for the 2nd Drug Development Forum is currently under development.

For information on speaking opportunities, please contact Matthew Greenbaum at or by calling 212-400-6242.

Key subject areas

  • Mergers & acquisitions to strengthen your drug pipeline 
  • Remote clinical monitoring and its impact on development speed 
  • The art of the biotech deal: creating syndicates and driving value 
  • Building relationships and networking with KOLs 
  • Prioritizing late-stage development programs 
  • Optimizing teamwork with CROs for drug development 
  • Biopharma alliances with venture capitalists and academic researchers 
  • Avoiding the riskiest pitfalls in early outsourced biotech operations 
  • Team-based approaches to securing “breakthrough” designation from FDA 
  • The greatest challenges in product valuation 
  • Selecting ideal partners for emerging markets and orphan / specialty drugs 
  • Adapting to FDA’s “Fast Track” 
  • Engaging patients to avoid pitfalls in clinical research 
  • Recognizing changes in biotech funding sources and trends